Dr. Chao-Yu Yu Hsu, MD

Dr. Hsu practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Hsu's NPI, 1770695215, was assigned on August 31, 2006. Dr. Hsu graduated from University of Toronto Faculty of Medicine in 2002. Dr. Hsu holds New York license 263421.

Dr. Hsu's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Hsu's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Hsu is also affiliated with Clifton Springs Hospital and Clinic. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Hsu to 2 more dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hsu is licensed in New York.

CMS data shows 574 Medicare services from Dr. Hsu across 10 procedure codes in 2024, for 189 Medicare patients. Medicare paid $65,761 for them.

CMS counts 189 Medicare patients who saw Dr. Hsu in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 50% are also on Medicaid. Their average risk score is 4.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 74, with 45% women.

In 2024, Dr. Hsu wrote 1,056 Medicare Part D claims for 229 patients. 91% of them were for generic drugs. CMS names the drug for 924 of them, across 24 drugs with 11 or more claims each, at $72,235 in total drug cost. In 2023, CMS named 810 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Hsu for performance year 2024, reported through an alternative payment model (APM). Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Dr. Hsu from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 65% of the total. Baxter Healthcare paid the most, $52.

Dr. Hsu graduated from University of Toronto Faculty of Medicine in 2002.